Back to Journals » Infection and Drug Resistance » Volume 13

Stenotrophomonas maltophilia Infections: Clinical Characteristics and Factors Associated with Mortality of Hospitalized Patients

Authors Insuwanno W, Kiratisin P, Jitmuang A

Received 14 March 2020

Accepted for publication 16 May 2020

Published 28 May 2020 Volume 2020:13 Pages 1559—1566

DOI https://doi.org/10.2147/IDR.S253949

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Suresh Antony


Worachart Insuwanno,1 Pattarachai Kiratisin,2 Anupop Jitmuang3

1Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; 2Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; 3Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

Correspondence: Anupop Jitmuang Email anupopmix@yahoo.co.th

Purpose: To study the clinical characteristics and factors associated with mortality of patients who had Stenotrophomonas maltophilia infections.
Patients and Methods: We conducted a retrospective study to determine the clinical characteristics and factors associated with mortality for S. maltophilia infections among hospitalized adult patients at Siriraj Hospital. The clinical and microbiological data were collected from medical records December 2013–December 2016.
Results: Of 1221 subjects whose clinical samples grew S. maltophilia, 213 were randomly selected for chart review. One hundred patients with a true infection were analyzed. Their median age was 66 years; 47 were males; 46 were critically ill with a median APACHE II score of 18 (2– 32); and 91 received antibiotic treatment, mainly with carbapenems (56%), before being diagnosed with a S. maltophilia infection. Pulmonary (53%) and bloodstream infections (25%) were the most common infections. The median length of hospitalization was 19 days before infection onset. The in-hospital mortality rate was 54%. The following factors were associated with mortality: a pre-existing respiratory infection (OR 6.28, 1.33– 29.78; p.021); critical illness (OR 3.33, 1.45– 7.62; p.005); multi-organ dysfunction (OR 2.44, 1.05– 5.70; p.039); being on mechanical ventilation (OR 4.44, 1.90– 10.39; p.001); concurrent immunosuppressive therapy (OR 2.67, 1.10– 6.47; p.029); intravascular (OR 4.43, 1.79– 10.92; p.001) and urinary catheterization (OR 4.83, 1.87– 12.47; p.001); and serum albumin < 3 g/dL (OR 4.13, 1.05– 16.33; p.043). A multivariate analysis identified two independent factors associated with mortality: being on mechanical ventilation (OR 4.43, 1.86– 10.59; p 0.001) and receiving concurrent immunosuppressive therapy (OR 2.26, 1.04– 6.82; p 0.042).
Conclusion: S. maltophilia can cause nosocomial infections with high mortality, particularly in patients with a prolonged hospitalization. Concurrent immunosuppressive therapy and being on mechanical ventilation are the independent factors associated with a fatal outcome.

Keywords: Stenotrophomonas maltophilia infection, hospitalized patients, mortality

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]